Mycophenolic acid (MPA) AUC(0-12H) in stable liver transplant patients treated with a monotherapy of mycophenolate mofetil (MMF) for calcineurin inhibitors (CNI) induced nephrotoxicity

被引：0
|
作者：
Dharancy, Sebastien
Hulin, Anne
Declerck, Nicole
Blanchet, Benoiet
Boleslawski, Emmanuel
Canva, Valerie
Mathurin, Philippe
Pruvot, Francois-Rene
机构：
[1] Hop Huriez, Transplant Unit, Lille, France
[2] Hop Henri Mondor, F-94010 Creteil, France
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
586
引用
收藏
页码：406A / 407A
页数：2
相关论文
共 24 条
  • [21] Diagnostic efficiency of truncated area under the curve from 0 to 2 h (AUC0-2) of mycophenolic acid in kidney transplant recipients receiving mycophenolate mofetil and concomitant tacrolimus
    Lampon, Natalia
    Tutor-Crespo, Maria J.
    Romero, Rafael
    Tutor, Jose C.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (07) : 1167 - 1170
  • [22] The Use of Higher Doses of Mycophenolic Acid (MPA) Is Not Associated with Worse Gastrointestinal Tolerability in Renal Transplant Patients Converted from Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS).
    Ortega, F.
    Sanchez-Fructuoso, A.
    Cruzado, J. M.
    Gomez-Alamillo, J. C.
    Alarcon, A.
    Pallardo, L.
    Morales, J. M.
    Oliver, J.
    Mora, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 512 - 512
  • [23] Mycophenolic Acid 12-Hour Area Under the Curve in De Novo Liver Transplant Patients Given Mycophenolate Mofetil at Fixed Versus Concentration-Controlled Doses
    Kamar, Nassim
    Marquet, Pierre
    Gandia, Peggy
    Muscari, Fabrice
    Lavayssi, Laurence
    Esposito, Laure
    Guitard, Joelle
    Canivet, Cindy
    Peron, Jean Marie
    Alric, Laurent
    Suc, Bertrand
    Saint-Marcoux, Franck
    Rostaing, Lionel
    [J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (04) : 451 - 456
  • [24] Validation of Limited Sampling Strategy for the Estimation of Mycophenolic Acid (MPA) Exposure in Kidney Transplant Patients (KTs) Treated with Enteric-Coated Mycophenolate Sodium (EC-MPS) and mTOR Inhibitors or Cyclosporine.
    Sanchez-Fructuoso, A. I.
    Calvo, N.
    Perez-Flores, I.
    Fernandez-Perez, C.
    Matilla, E.
    Barrientos, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 320 - 321
123